These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 9058668)
1. Antinuclear antibody positivity in pediatric patients with autoimmune thyroid disease. Inamo Y; Harada K J Rheumatol; 1997 Mar; 24(3):576-8. PubMed ID: 9058668 [TBL] [Abstract][Full Text] [Related]
2. Association of circulating antibodies against double-stranded and single-stranded DNA with thyroid autoantibodies in Graves' disease and Hashimoto's thyroiditis patients. Pedro AB; Romaldini JH; Americo C; Takei K Exp Clin Endocrinol Diabetes; 2006 Jan; 114(1):35-8. PubMed ID: 16450315 [TBL] [Abstract][Full Text] [Related]
4. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy. Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Barani L; Ferrannini E; Serio M Clin Endocrinol (Oxf); 2006 Feb; 64(2):189-95. PubMed ID: 16430719 [TBL] [Abstract][Full Text] [Related]
5. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease. Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328 [TBL] [Abstract][Full Text] [Related]
6. Treatment outcome of Graves' disease in Thai children. Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924 [TBL] [Abstract][Full Text] [Related]
7. The presence of the antigliadin antibodies in autoimmune thyroid diseases. Akçay MN; Akçay G Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cclxxix-cclxxx. PubMed ID: 15244201 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO). Giovanella L; Ceriani L; Garancini S Q J Nucl Med; 2001 Mar; 45(1):115-9. PubMed ID: 11456370 [TBL] [Abstract][Full Text] [Related]
9. The quantitative measurement of autoantibodies to thyroglobulin and thyroid peroxidase by automated microparticle based immunoassays in Hashimoto's disease, Graves' disease and a follow-up study on postpartum thyroid disease. Gilmour J; Brownlee Y; Foster P; Geekie C; Kelly P; Robertson S; Wade E; Braun HB; Staub U; Michel G; Lazarus JH; Parkes AB Clin Lab; 2000; 46(1-2):57-61. PubMed ID: 10745983 [TBL] [Abstract][Full Text] [Related]
11. Anti-nuclear antibody, anti-DNA, and aCL in Graves' disease patients treated with propyluracil or methimazole. Huang CN; Hsu TC; Chou HH; Tsay GJ Lupus; 2004; 13(6):450-4. PubMed ID: 15303572 [TBL] [Abstract][Full Text] [Related]
12. Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases. Tektonidou MG; Anapliotou M; Vlachoyiannopoulos P; Moutsopoulos HM Ann Rheum Dis; 2004 Sep; 63(9):1159-61. PubMed ID: 15308528 [TBL] [Abstract][Full Text] [Related]
13. Endothelin-1 levels in patients with disorders of the thyroid gland. Tilly N; Schneider JG; Leidig-Bruckner G; Sommer U; Kasperk C Exp Clin Endocrinol Diabetes; 2003 Apr; 111(2):80-4. PubMed ID: 12746758 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and early diagnosis of coeliac disease in autoimmune thyroid disorders. Cuoco L; Certo M; Jorizzo RA; De Vitis I; Tursi A; Papa A; De Marinis L; Fedeli P; Fedeli G; Gasbarrini G Ital J Gastroenterol Hepatol; 1999 May; 31(4):283-7. PubMed ID: 10425571 [TBL] [Abstract][Full Text] [Related]
15. Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy. Wakelkamp IM; Prummel MF; Wiersinga WM Horm Metab Res; 2004 Jan; 36(1):44-7. PubMed ID: 14983406 [TBL] [Abstract][Full Text] [Related]
16. [Two-center evaluation of eight kits for antithyroid peroxidase autoantibodies determinations]. d'Herbomez M; Sapin R; Gasser F; Schlienger JL; Wémeau JL Ann Biol Clin (Paris); 2000; 58(4):445-51. PubMed ID: 10932045 [TBL] [Abstract][Full Text] [Related]
17. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy. Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393 [TBL] [Abstract][Full Text] [Related]
18. [Prevalence and predictive factors of parietal cell antibody positivity in autoimmune thyroid disease]. García García B; Gimeno Orna JA; Aguillo Gutiérrez E; Altemir Trallero J; Cabrejas Gómez C; Ilundaín González A; Lázaro Puente F; Ocón Bretón J; Faure Nogueras E Endocrinol Nutr; 2010 Feb; 57(2):49-53. PubMed ID: 20149767 [TBL] [Abstract][Full Text] [Related]
19. Detection of antipituitary antibodies in patients with autoimmune thyroid disease. Nishino M; Yabe S; Murakami M; Kanda T; Kobayashi I Endocr J; 2001 Apr; 48(2):185-91. PubMed ID: 11456266 [TBL] [Abstract][Full Text] [Related]
20. Should Graves' disease be considered a collagen disorder of the thyroid, skeletal muscle and connective tissue? Kiljanski J; Nebes V; Stachura I; Kennerdell JS; Wall JR Horm Metab Res; 1995 Dec; 27(12):528-32. PubMed ID: 8750780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]